MyPharmacy+

Skelafit Mango Sugar Free Granules

Manufactured By Edura Pharmaceuticals Pvt Ltd

Salt Synonyms

Rs. 99.00

MRP 110.00

(10% OFF)

Includes all taxes

Package SIZE

sachet of 10.7 gm Granules

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Skelafit Mango Sugar Free Granules

Uses / Indications:

Take Skelafit Granules as directed by the physician.

Introduction:

Skelafit Granules Collagen is one of the primary ingredient of the product which is abundant in blood vessels the cornea intervertebral discs the blood-brain barrier dentin and the intestinal wall. The product is one of the best remedy for reduction of wrinkles and signs of aging. It also assists in the treatment of oesteoarthritis.

How to use:

It is used as building blocks renewing bodily tissues such as skin bones and joints|It provides elasticity to the skin helping it to appear more youthful and healthy|It helps in reducing skin wrinkles|Reduces pain and inflammation of the body|Useful in the treatment of osteoarthritis rheumatoid arthritis and inflammatory

Description:

It supplies amino acids which are valuable building blocks in the body|Stimulates the cell synthesis|It helps in delaying the skin wrinkles

Benefits:

Safety Advise:

Skelafit Mango Sugar Free Granules

Manufactured By Edura Pharmaceuticals Pvt Ltd

Salt Synonyms

Rs. 99.00

MRP 110.00

Includes all taxes

Package SIZE

Available Substitutes

1MD Nutrition Alpha-Lipoic Acid Capsule

1MD Nutrition

1MD Nutrition L-Arginine+ Tablet

1MD Nutrition

5 Pro Active Protein Powder Vanilla Toffee

Nouvelle Pharmaceuticals

Erise-LC Tablet

Qcl Life Science Pvt Ltd

Erizyne-Q10 Softgel Capsule

Eridanus Healthcare

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: